MX2018009522A - Metodos y composiciones para el tratamiento y control de enfermedades en las plantas. - Google Patents

Metodos y composiciones para el tratamiento y control de enfermedades en las plantas.

Info

Publication number
MX2018009522A
MX2018009522A MX2018009522A MX2018009522A MX2018009522A MX 2018009522 A MX2018009522 A MX 2018009522A MX 2018009522 A MX2018009522 A MX 2018009522A MX 2018009522 A MX2018009522 A MX 2018009522A MX 2018009522 A MX2018009522 A MX 2018009522A
Authority
MX
Mexico
Prior art keywords
control
methods
treatment
plant
compositions
Prior art date
Application number
MX2018009522A
Other languages
English (en)
Inventor
Carlos F Gonzalez
Stephen J Ahern
Mayukh Das
Iii Ryland F Young
Tushar Suvra Bhowmick
Original Assignee
Texas A & M Univ Sys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M Univ Sys filed Critical Texas A & M Univ Sys
Publication of MX2018009522A publication Critical patent/MX2018009522A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10231—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10233—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10331—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a una composición de biocontrol de enfermedades vegetales formulad para la administración que comprende un agente amortiguador de p H, y al menos dos aislados de bacteriófago del tipo de fago Xfas100 o del tipo de fago Xfas300, o ambos; en donde cada uno de dichos aislados de bacteriófago es virulento para Xylella fastidiosa y especies de Xanthomonas, y los bacteriófagos son capaces de lisar dicha Xylella fastidiosa o bacterias Xanthomonas, en donde adicionalmente el tipo de fago Xfas100 presenta las siguientes características: (a) el bacteriófago infecta una célula mediante su unión a un pelo de Tipo IV; (b) el bacteriófago comprende una cola no contráctil y un tamaño de cápside que caría en un rango d 55-77 nm en diámetro y pertenece a la familia Siphoviridae; (c) el tamaño genómico del bacteriófago es de aproximadamente 55500 pb a 56200 pb; y (d) el bacteriófago previene o reduce los síntomas asociados con la enfermedad de Pierce en una planta o plantas; y en donde adicionalmente el tipo de fago Xfas300 presente las siguientes características: ( e) el bacteriófago infecta una célula mediante su unión a un pelo de Tipo IV; (f) el bacteriófago comprende una cola no contráctil y un tamaño de cápside que varía en un rango de 58-68 nm en diámetro y pertenece a la familia Podoviridae, (g) el tamaño genómico del bacteriófago es de aproximadamente 43300 pb a 44600 pb; y (h) el bacteriófago previene o reduce los síntomas asociados con la enfermedad de Pierce en una planta o plantas.
MX2018009522A 2012-10-19 2015-04-17 Metodos y composiciones para el tratamiento y control de enfermedades en las plantas. MX2018009522A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261716245P 2012-10-19 2012-10-19
US201361785535P 2013-03-14 2013-03-14

Publications (1)

Publication Number Publication Date
MX2018009522A true MX2018009522A (es) 2021-11-16

Family

ID=50488903

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015004951A MX2015004951A (es) 2012-10-19 2013-10-18 Metodos y composiciones para el tratamiento y control de enfermedades en las plantas.
MX2018009522A MX2018009522A (es) 2012-10-19 2015-04-17 Metodos y composiciones para el tratamiento y control de enfermedades en las plantas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015004951A MX2015004951A (es) 2012-10-19 2013-10-18 Metodos y composiciones para el tratamiento y control de enfermedades en las plantas.

Country Status (20)

Country Link
US (3) US9357785B2 (es)
EP (2) EP2909317B1 (es)
JP (4) JP6391579B2 (es)
CN (2) CN109536458A (es)
AR (1) AR093061A1 (es)
AU (1) AU2013331060B2 (es)
BR (1) BR112015008517A2 (es)
CL (1) CL2015000986A1 (es)
CR (1) CR20150218A (es)
EA (1) EA201590766A1 (es)
ES (1) ES2774291T3 (es)
GT (1) GT201500091A (es)
HU (1) HUE047411T2 (es)
IN (1) IN2015DN04230A (es)
MX (2) MX2015004951A (es)
NZ (2) NZ747298A (es)
PE (1) PE20151287A1 (es)
PT (1) PT2909317T (es)
WO (1) WO2014063070A2 (es)
ZA (1) ZA201502230B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10499651B2 (en) 2012-10-19 2019-12-10 The Texas A&M University System Method for treatment and control of plant disease
WO2014063070A2 (en) 2012-10-19 2014-04-24 The Texas A&M University System Methods and compositions for treatment and control of plant disease
JP2016032435A (ja) * 2014-07-30 2016-03-10 国立大学法人広島大学 バクテリオファージ、カンキツかいよう病菌の検出剤、カンキツかいよう病菌の検出方法、カンキツかいよう病の防除剤およびカンキツかいよう病の防除方法
US11058131B2 (en) 2015-04-16 2021-07-13 Kennesaw State University Research And Service Foundation, Inc. Escherichia coli O157:H7 bacteriophage Φ241
CA3075434A1 (en) * 2017-09-15 2019-03-21 Syntbiolab Inc. Bacteriophage composition and method of preventing bacterial infections in livestock
US20210219549A1 (en) * 2018-06-28 2021-07-22 University Of Florida Research Foundation, Inc. Menadione compositions for treating plant diseases in grape plants and citrus
CN110352880B (zh) * 2019-08-13 2021-04-20 宁波大学 一种紫菜黄斑病的治疗方法
EP3885355A1 (en) 2020-03-24 2021-09-29 Universidade de Évora A viral molecule for protecting plants against the bacteria xylella fastidiosa
CN111789132A (zh) * 2020-07-04 2020-10-20 菲吉乐科(南京)生物科技有限公司 一种新型复合制剂及其在细菌性病害中的应用
CN113201504B (zh) * 2021-02-19 2022-09-06 青岛诺安百特生物技术有限公司 一株防治植物黄单胞菌感染的噬菌体及其应用
CN113151192B (zh) * 2021-03-05 2023-11-24 菲吉乐科(南京)生物科技有限公司 一种可跨种裂解的黄单胞菌噬菌体和其组合物、试剂盒和应用
GB202210435D0 (en) * 2022-07-15 2022-08-31 Carus Animal Health Ltd Agricultural compositions and methods
EP4374696A1 (en) 2022-11-27 2024-05-29 Special Research Fund Account (ELKE) Hellenic Mediterranean University Antibacterial formulations against members of xanthomonadaceae family preventing plant diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828999A (en) 1986-07-21 1989-05-09 Jackson Le Roy E Bacteriophage prevention and control of harmful plant bacteria
US8212110B2 (en) * 2003-05-14 2012-07-03 Integrated Plant Genetics, Inc. Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
JP2005073562A (ja) * 2003-08-29 2005-03-24 National Agriculture & Bio-Oriented Research Organization ファージならびに植物非病原性細菌を利用した地上部植物細菌病害防除法
WO2008062310A2 (en) * 2006-05-19 2008-05-29 Hornedo Jose Luis Stephano Elimination of the bacteria that cause pierce's disease
BRPI0814440A2 (pt) * 2007-07-19 2014-08-19 Integrated Plant Genetics Inc Uso de proteínas de ruptura de membrana exterior de bacteriófago expressas em plantas para o controle de bactérias gram-negativas
EP2103308A1 (de) * 2008-03-20 2009-09-23 PhytoLine GmbH Verfahren zur Herstellung eines Gemisches von Bakteriophagen und deren Verwendung für die Therapie von Antibiotika-resistenten Staphylococcen
US9486007B2 (en) * 2008-03-25 2016-11-08 Ecolab Usa Inc. Bacteriophage treatment for reducing and preventing bacterial contamination
EP2168592A1 (en) 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
US20110294668A1 (en) * 2008-12-08 2011-12-01 North Carolina State University Inhibition and dispersion of biofilms in plants with imidazole-triazole derivatives
EP2465926A1 (en) 2010-12-20 2012-06-20 University College Cork Pseudomonas aeruginosa Bacteriophage and uses thereof
WO2014063070A2 (en) 2012-10-19 2014-04-24 The Texas A&M University System Methods and compositions for treatment and control of plant disease
US10499651B2 (en) 2012-10-19 2019-12-10 The Texas A&M University System Method for treatment and control of plant disease

Also Published As

Publication number Publication date
EP2909317A2 (en) 2015-08-26
JP2015534983A (ja) 2015-12-07
PT2909317T (pt) 2020-02-19
AU2013331060A1 (en) 2015-05-07
GT201500091A (es) 2017-09-21
CN104994740B (zh) 2019-02-15
CL2015000986A1 (es) 2016-02-05
EA201590766A1 (ru) 2015-10-30
IN2015DN04230A (es) 2015-10-16
US9357785B2 (en) 2016-06-07
EP2909317A4 (en) 2016-07-20
HUE047411T2 (hu) 2020-04-28
US20160302426A1 (en) 2016-10-20
BR112015008517A2 (pt) 2017-12-05
CN109536458A (zh) 2019-03-29
ES2774291T3 (es) 2020-07-20
US10212941B2 (en) 2019-02-26
MX2015004951A (es) 2016-07-21
JP6391579B2 (ja) 2018-09-19
WO2014063070A2 (en) 2014-04-24
EP2909317B1 (en) 2019-10-16
JP2018150340A (ja) 2018-09-27
NZ747298A (en) 2020-07-31
US20150257392A1 (en) 2015-09-17
NZ707094A (en) 2018-12-21
WO2014063070A3 (en) 2015-07-16
CN104994740A (zh) 2015-10-21
ZA201502230B (en) 2017-09-27
JP7276901B2 (ja) 2023-05-18
US10499650B2 (en) 2019-12-10
JP2021102635A (ja) 2021-07-15
AR093061A1 (es) 2015-05-13
AU2013331060B2 (en) 2017-07-13
PE20151287A1 (es) 2015-10-08
US20140140961A1 (en) 2014-05-22
CR20150218A (es) 2015-09-11
JP2023055862A (ja) 2023-04-18
EP3620515A1 (en) 2020-03-11

Similar Documents

Publication Publication Date Title
MX2018009522A (es) Metodos y composiciones para el tratamiento y control de enfermedades en las plantas.
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
MX2015014431A (es) Monoterapia con glucopiranosil lipido a para usarse en el tratamieto del cancer.
MX2014000373A (es) Moleculas de enlace humanas capaces de neutralizar los virus de la influenza a del grupo filogenetico 1 y grupo filogenetico 2 y el virus de influenza b.
NZ708928A (en) Mannose derivatives for treating bacterial infections
IN2014CN03555A (es)
HK1200086A1 (en) Methods and compositions relating to p62 for the treatment and prophylaxis of cancer p62
CL2011002639A1 (es) Cepa bacteriana de mycoplasma bovis atenuada avirulenta; composicion inmunogenica que la comprende; y uso para fabricar un medicamento para infecciones producidas por m. bovis.
MX2016008226A (es) Metodos para el cuidado oral prebiotico usando un sacarido.
AU2018256482A1 (en) Antibodies Against Clostridium Difficile
NZ594019A (en) Novel antibacterial agents for the treatment of gram positive infections
PH12014502680A1 (en) Polysaccharide compositions and methods of use
MX2012014163A (es) Uso de acido sialico, precursor de acido sialico o una combinacion de los anteriores para preparar medicamentos utiles en una condicion diabetica o sindrome nefrotico.
IN2014DN05865A (es)
CL2014003549A1 (es) Producción de cultivos protozoarios de histomonas meleagridis; y formulación de vacuna que comprende un cultivo atenuado de h. meleagridis y al menos un cultivo bacteriano de una cepa única.
MX2015005165A (es) Cepas de streptococcus thermophilus para tratar infeccion por helicobacter pylori.
MX349944B (es) Lactobacillus brevis productor de reuterina.
AR117197A2 (es) Métodos y composiciones para el tratamiento y control de enfermedades en las plantas
PH12015501147A1 (en) Synbiotic composition and use thereof
NZ606186A (en) Use of lactoferrin to treat proteinuria
IN2014DN07989A (es)
PT2657321T (pt) Gasogénio para a produção de gases para combustão externa em caldeiras que utilizam os referidos gases e o processo para melhorar o tratamento de biomassa por meio do gasogénio
UA79564U (ru) Способ обезжелезивания воды
MX341213B (es) Uso de nifuratel para tratar infecciones causadas por una especie del genero clostridium.
UA72222U (ru) Способ лечения геликобактер-ассоциированной язвенной болезни у детей